A company files for bankruptcy. Its owners try to get immunity anyway.
2019
Year Purdue Pharma filed for bankruptcy, facing mass opioid litigation
$0
Bankruptcy filings made personally by Sackler family members — none
2024
Year the US Supreme Court rejected the original settlement's family shield
$7.4B
Value of the revised settlement ultimately reached
FACTPurdue Pharma, maker of OxyContin, filed for corporate bankruptcy in 2019 while facing sweeping litigation over its role in the US opioid crisis.
FACTThe Sackler family, which owned and controlled Purdue, did not personally file for bankruptcy. The original plan released claims against family members and related nondebtors, including claims held by people who had not consented to the release, in exchange for a family contribution.
INFERENCEThe structural concern is not that settlement always equals immunity. It is that owners could receive the central benefit of bankruptcy—a release from claims—without placing all their assets under bankruptcy administration or obtaining each affected claimant's consent.